Provision Language
<p><em><strong>Definitionsstrong>em>p>
<p class=”p1“><b>“BDSI Background IP” b>means (a) any <a href=”#kt“>Patentsa> or patent applications either granted or filed by BDSI and which are necessary or useful in the optimization, development, manufacturing, or distribution of CAMB and (b) any <a href=”#kt“>Know-Howa> developed by or on behalf of BDSI which relates to CAMB.p>
<p><b>“Collaboration IP”b><span style=”font–weight: 400;”> means (a) any Know-How made, developed or conceived under the R&D Plan according to this Agreement in each case solely or jointly by an employee, consultant or agent of DNDi or BDSI or their respective Affiliates, subcontractors or sublicensees, (b) any Patents describing, claiming or covering the Know-How developed according to section 1.6, a, and (c) any other intellectual property rights in or to such Know-How.span>p>
<p class=”p1“><b>“Distribution” b>means all activities that are undertaken after obtaining Regulatory Approval to make CAMB available to prescribers and/or users in the Territory for use in the Fieldp>
<p class=”p1“><b>“Distribution Through the Public Sector” b>means Distribution, disposition or use of CAMB in the Territory for use in the Field by a <a href=”#kt“>Public Sector Agencya>.p>
<p class=”p1“><b>“Territory” b>means all countries of the world excluding Japan, Australia, New Zealand, Russia, CIS countries, China, and all countries in North America and any country in, or that joins the European Union.p>
<p><span style=”text–decoration: underline;”><b>4. LICENSESb>span>p>
<p><b>4.1 Licenses to DNDi.b><span style=”font–weight: 400;”> Subject to all of the terms and conditions of this Agreement, BDSI hereby grants DNDi: span>p>
<p style=”padding–left: 25px;”><span style=”font–weight: 400;”>(a) a worldwide, non–exclusive, royalty–free and fully paid–in, sublicensable (as permitted under Section 4.3) license to use BDSI Background IP for the purpose of conducting DNDi’s activities under the R&D Plan; span>p>
<p style=”padding–left: 25px;”><span style=”font–weight: 400;”>(b) an non–exclusive, royalty–free, irrevocable and fully paid–in, sublicensable (as permitted under Section 4.3) license to use BDSI Background IP and Collaboration IPR for the purpose of seeking <a href=”#kt“>Regulatory Approvalsa> and undertaking Distribution Through the Public Sector in the Territory for use in the Field; provided, however that if, for any reason, BDSI is unable to supply CAMB ordered by DNDi or its nominee for Distribution Through the Public Sector, for use in the Field, in the Territory, this exclusive license shall be automatically extended to include the right for DNDi to manufacture CAMB, or to have CAMB manufactured by any Third Party, for the sole purpose of its Distribution Through the Public Sector in the Territory for use in the Field, subject to section 3.3. span>p>
<p><b>4.2 License to BDSI.b><span style=”font–weight: 400;”> Subject to the terms and conditions of this Agreement, DNDi hereby grants BDSI a worldwide, exclusive, royalty–free, irrevocable and fully paid–in, sublicensable, license to make, have made, use, have used, offer to sell, sell, have sold, or import or have imported CAMB under the Collaboration IP (as defined under <span style=”text–decoration: underline;”><a href=”https://ghiaa.org/provision_document/drugs–for–neglected–diseases–initiative–biodelivery–sciences–international–visceral–leishmaniasis–research–collaboration–agreement/” target=”_blank” rel=”noopener“>Section 6.1a>span>). span>p>
<p><b>4.3 Sublicensing.b><span style=”font–weight: 400;”> DNDi may grant sublicenses to its Affiliates or to Third Parties under the licenses granted in Section 4.1 with the prior written consent of BDSI, not to be unreasonably withheld, provided that each approved sublicensee agrees to be bound by the terms of this Agreement. span>p>
<p><b>4.4 No Implied Rights or Licenses;b> <b>Retained Rights.b><span style=”font–weight: 400;”> Neither Party grants to the other Party any rights or licenses, including without limitation to any Patent, Know-How, or other intellectual property rights, by implication, estoppel or otherwise, except to the extent expressly provided in this Agreement. BDSI retains all rights in the BDSI Background IP and Collaboration IP that are not granted to DNDi in Section 4.1 or <span style=”text–decoration: underline;”><a href=”https://ghiaa.org/provision_document/drugs–for–neglected–diseases–initiative–biodelivery–sciences–international–visceral–leishmaniasis–research–collaboration–agreement/” target=”_blank” rel=”noopener“>6.1a>span>, including all rights to manufacture, sell and Distribute CAMB in the Territory in any manner and context that is not Distribution Through the Public Sector. span>p>
<p><b>4.5 Limitation to Territory.b><span style=”font–weight: 400;”> DNDi and its Affiliates, sublicensees, and distributors shall not Distribute CAMB outside the Territory or for use outside the Field, or conduct any Distribution except for Distribution Through the Public Sector. DNDi and its Affiliates, sublicensees, and distributors shall refer to BDSI any inquiries or orders for CAMB that they receive, where DNDi believes the use will be outside of the Field, or from outside the Territory or from any Third Party other than Public Sector Agencies. DNDi shall additionally take all reasonable steps ((as further described in <span style=”text–decoration: underline;”><a href=”https://ghiaa.org/provision_document/drugs–for–neglected–diseases–initiative–biodelivery–sciences–international–visceral–leishmaniasis–research–collaboration–agreement–4/” target=”_blank” rel=”noopener“>section 3.3 (b)a>span>, and such as by example, but not limitation, changes in packaging and trade dress, use of tamper resistant materials and the like), necessary and work with and assist BDSI in preventing the redistribution, parallel importation or diversion of DNDi’s supply of CAMB.span>p>
<p><span style=”text–decoration: underline;”><b>6. b><b>INTELLECTUAL PROPERTYb>span>p>
<p>[…]p>
<p><b>6.6 Patent and Trademark Marking. b><span style=”font–weight: 400;”>Each Party shall mark, if necessary and requested by a Party, all materials manufactured, supplied or used under the terms of this Agreement, or their containers, in accordance with the applicable Patent and Trademark marking Laws in conjunction with and at the direction of the Party holding any patents or trademarks covering CAMB.span>p>